Home
Conditions
Triple Negative Breast Neoplasms

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies

Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC

NCT06700382

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC

NCT06692725

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

NCT04787042

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +43 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

Yale Cancer Center New Haven, Connecticut, United States

Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer

NCT06532812

Conditions: Breast Cancer, Breast Cancer Metastatic, Breast Cancer Triple Negative, +8 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC

NCT06533384

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

NCT05403554

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +26 more
Locations: Institut Curie Paris, France

Hôpital Européen Georges Pompidou Paris, France

Centre Eugène Marquis Rennes, France

Gustave Roussy Villejuif, France, France

View Trial Details

Recruiting

The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer

NCT05550415

Conditions: Breast Diseases, Breast Neoplasms, Chemotherapy Effect, +7 more
Locations: Dr. Cipto Mangunkusumo National Central General Hospital Jakarta Pusat, DKI Jakarta, Indonesia

View Trial Details

Recruiting

NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial

NCT06342037

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +5 more
Locations: Antoni van Leeuwenhoek Amsterdam, North Holland, Netherlands

View Trial Details

Recruiting

CTS2190 Phase I /II Clinical Study in Patients

NCT06224387

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +22 more
Locations: The First Affiliated Hospital of Henan University of Science and Technology Luoyang, Henan, China

Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

NCT06534762

Conditions: Breast Diseases, Breast Neoplasms, Carcinoma, +45 more
Locations: Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China

View Trial Details

Triple Negative Breast Neoplasms

Triple Negative Breast Neoplasms trial results

Related conditions